Skip to main content
. 2019 Oct;10(5):944–956. doi: 10.21037/jgo.2019.05.10

Table 4. Objective response rates post treatment at 3 months.

Response Target lesion Overall
RECIST PERCIST RECIST PERCIST
All (n=8)
   CR 0 1 0 1
   PR 0 4 0 3
   SD 8 2 5 1
   PD 0 1 3 3
PC (n=3)
   CR 0 0 0 0
   PR 0 1 0 0
   SD 3 1 0 0
   PD 0 1 3 3
ICC (n=5)
   CR 0 1 0 1
   PR 0 3 0 3
   SD 5 1 5 1
   PD 0 0 0 0

PC, pancreatic cancer; ICC, intrahepatic cholangiocarcinoma; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.